secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2026-09-11T21:00:14+00:00
Accession:  0001683168-26-007090
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma cuts Series B warrant exercise price to $1.2046
------------------------------------------------------------------

- As of September 11, 2026, Sunshine Biopharma reduced its Series B Warrant exercise price to $1.2046.
- Reduction stems from recent common-stock sales under the company's at-the-market offering.
- The exercise price remains subject to further adjustment per Series B Warrant terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316826007090/0001683168-26-007090-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316826007090/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-007090

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer